Dr. Hagar Labouta is a Scientist at Keenan Research Center for Biomedical Science and an Assistant Professor at University of Toronto at both Leslie Dan Faculty of Pharmacy and Institute of Biomedical Engineering. She is expert in nanomedicine, drug delivery, and biomedical engineering. Before joining the University of Toronto, she was an Assistant Professor at the College of Pharmacy, University of Manitoba. She got her Ph.D. in pharmaceutical nanotechnology from Saarland University (Germany). She completed several Postdoctoral fellowships at the Helmholtz Institute for Pharmaceutical Research Saarland (Germany), and the Departments of Chemistry and Biomedical Engineering, University of Calgary (Canada).
Dr. Labouta leads a unique research program that utilizes cutting-edge nanotechnologies, microfluidics and organ-on-a-chip technologies to design and evaluate nanoparticles (NPs) to breach biological barriers and enable site-specific delivery. She has successfully attracted funding from national and international agencies and has a strong publication record. She is a co-inventor on an international patent for the development of nanosystems for intracellular targeting. She has won several awards and fellowships including the CRS member of the year award from the Controlled Release Society, Interstellar Award from New York Academy of Sciences, Innovation and Career Development Award by the Biomedical Engineering Society, Apotheker Jacob Prize for the best PhD thesis in pharmaceutical sciences in Germany, and curriculum award for the Nanoscience Minor Program from Taylor Institute in Canada. She serves as an Associate Editor in the Drug Delivery and Translational Research (DDTR) and is on the editorial board of Journal of Controlled Release. She has served on several grant panels in Canada and otherwise. She was an invited speaker, including as a keynote speaker, at several conferences in the USA, Australia, Canada, etc. She has established important collaborations in Canada and globally.
